期刊
INTERNAL MEDICINE
卷 60, 期 16, 页码 2651-2657出版社
JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.6640-20
关键词
adenine phosphoribosyltransferase deficiency; 2,8-dihydroxyadenine; kidney transplantation; renal biopsy; graft loss
资金
- Science and Technology Department of Zhejiang Province [2019C 03029]
- Bethune Charitable Foundation [G-X-2019-0101-12]
- National Natural Science Foundation of China [81870510]
This case report highlights a kidney transplant patient who experienced recurrent obstructive nephropathy post-transplantation, later identified by gene testing as having APRT deficiency. Treatment with allopurinol resulted in progressive improvement of allograft function. Additionally, 20 cases of APRT deficiency in renal transplant recipients were reviewed, emphasizing the importance of early recognition and treatment to avoid misdiagnosis or delayed diagnosis.
We herein report the case of a kidney transplant patient with recurrence of obstructive nephropathy that was not diagnosed as adenine phosphoribosyltransferase (APRT) deficiency until gene testing identified a pathogenic homozygous variant three years after renal transplantation. Subsequently, the patient was treated with allopurinol, and the allograft function increased progressively to normal. In addition, 20 cases of APRT deficiency in renal transplant recipients were also reviewed. We hope this case increases awareness of APRT deficiency in repeated obstructive nephropathy post-transplantation, which is a treatable disease for which the misdiagnosis or delayed diagnosis should be avoided.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据